These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 2679072

  • 1. Clinical experience with antithrombin III concentrate in treatment of congenital and acquired deficiency of antithrombin. The Antithrombin III Study Group.
    Schwartz RS, Bauer KA, Rosenberg RD, Kavanaugh EJ, Davies DC, Bogdanoff DA.
    Am J Med; 1989 Sep 11; 87(3B):53S-60S. PubMed ID: 2679072
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transfusion studies in patients with familial antithrombin III (ATIII) deficiency: half-disappearance time of infused ATIII and influence of such infusion on platelet life-span.
    Winter JH, Fenech A, Bennett B, Douglas AS.
    Br J Haematol; 1981 Nov 11; 49(3):449-53. PubMed ID: 7295588
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Congenital antithrombin III deficient neonate treated with antithrombin III concentrates.
    Shiozaki A, Arai T, Izumi R, Niiya K, Sakuragawa N.
    Thromb Res; 1993 May 01; 70(3):211-6. PubMed ID: 8327986
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Uses of antithrombin III concentrate in congenital and acquired deficiency states.
    Bucur SZ, Levy JH, Despotis GJ, Spiess BD, Hillyer CD.
    Transfusion; 1998 May 01; 38(5):481-98. PubMed ID: 9633563
    [No Abstract] [Full Text] [Related]

  • 15. Congenital antithrombin III deficiency. Incidence and clinical features.
    Hirsh J, Piovella F, Pini M.
    Am J Med; 1989 Sep 11; 87(3B):34S-38S. PubMed ID: 2679068
    [Abstract] [Full Text] [Related]

  • 16. Effective prophylaxis of thrombosis by antithrombin III concentrate in a pregnant woman with congenital antithrombin III deficiency: relations between plasma antithrombin III activity and the plasma levels of hemostatic molecular markers.
    Inomoto T, Takamoto M, Tamura R, Maegawa M, Kamada M, Takayanagi M.
    Haemostasis; 1991 Sep 11; 21(3):147-54. PubMed ID: 1773985
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia.
    Emerson TE, Fournel MA, Redens TB, Taylor FB.
    Am J Med; 1989 Sep 11; 87(3B):27S-33S. PubMed ID: 2679067
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies.
    Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P.
    Chest; 1992 Mar 11; 101(3):816-23. PubMed ID: 1531791
    [Abstract] [Full Text] [Related]

  • 20. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
    Büller HR, Weenink AH, Treffers PE, Kahlé LH, Otten HA, ten Cate JW.
    Scand J Haematol; 1980 Jul 11; 25(1):81-6. PubMed ID: 7444377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.